lobbying_activities: 2963228

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2963228	e3e3c44f-ada4-4240-bc15-eb44d4d0ff40	Q1	ASSOCIATION FOR ACCESSIBLE MEDICINES	16032	ASSOCIATION FOR ACCESSIBLE MEDICINES	2023	first_quarter	CPT	Patent Settlements. Patent Abuse. Skinny Labeling. Inter Partes Review. Impact of IPR decisions on 30-month stay. IPR Amendments. Cornyn-Leahy IPR Proposals. Patent Quality. Enhancing Quality of Patents through the Patent Trial and Appeal Board (PTAB). Patent Listings in Orange Book. S.79: Interagency Patent Coordination and Improvement Act of 2023. S.113: Prescription Pricing for the People Act of 2023. S.142: Preserve Access to Affordable Generics and Biosimilars Act. S.148: Stop STALLING Act. S.150: Affordable Prescriptions for Patients Act of 2023.	HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Patent & Trademark Office (PTO),SENATE		480000	0	0	2023-04-18T08:48:45-04:00